跳至主要内容
临床试验/NCT02766855
NCT02766855已完成不适用

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

The Eye Center and The Eye Foundation for Research in Ophthalmology0 个研究点目标入组 26 人开始时间: 2004年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
26
主要终点
Number of participants with improvement of photophobia, corneal cystine crystals and visual acuity following treatment with topical cysteamine 0.55% eye drops in patients with nephropathic cystinosis.

研究概览

简要总结

The aim of this study is to evaluate the efficacy of topical cysteamine eye drops in the treatment of corneal cystine crystals deposits in patients with nephropathic cystinosis.

详细描述

A total of 26 patients with nephropathic cystinosis were included in this prospective study. Patients were evaluated for improvement of corneal cysteine deposits crystals and photophobia following treatment with topical 0.55% cysteamine eye drops.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
8 Months 至 19 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • patients with confirmed diagnosis of nephropathic cystinosis
  • leucocyte cystine concentration level of more than 2.0 nmol half-cystine/ mg protein
  • clinical evidence of tissue deposition of cystine and tissue damage due to cystinosis

排除标准

  • Allergy to cysteamine

研究组 & 干预措施

cysteamine eye drops

Experimental

Patients used cysteamine eye drops every 2 hours while awake to both eyes.

干预措施: Cysteamine (Drug)

结局指标

主要结局

Number of participants with improvement of photophobia, corneal cystine crystals and visual acuity following treatment with topical cysteamine 0.55% eye drops in patients with nephropathic cystinosis.

时间窗: Photophobia, slit lamp assessment of corneal cystine crystals and visual acuity are recorded pretreatment, on each monthly visit up to 48 months.

Patients had a baseline ophthalmic examination before initiation of topical cysteamine 0.55% eye drops and subsequent monthly follow up exams. The following parameters were recorded pretreatment, on each monthly visit and post treatment at last follow up visit: photophobia, slit lamp assessment of corneal cystine crystals and visual acuity. Photophobia was classified as grade 0 (none) for no photophobia, grade 1 (mild) for photophobia in bright light, grade 2 (moderate) for photophobia in room light and grade 3 (severe) for photophobia in dim light. Corneal cystine crystals were graded as Grade 0 = None, Grade 1 = 1-10 crystals/mm, Grade 2 = 11- 50 crystals/mm, Grade 3 = more than 50 crystals/mm. The level of cystine in the corneal layers was recorded and the location whether peripheral or central was also identified. Visual acuity was measured by Snellen chart at 20 feet with best distance correction.

次要结局

未报告次要终点

研究者

发起方
The Eye Center and The Eye Foundation for Research in Ophthalmology
申办方类型
Other
责任方
Principal Investigator
主要研究者

Samir S. Shoughy, MD, FRCS (Glasg.)

Ophthamolgist, uveitis, Cornea & External Eye Disease

The Eye Center and The Eye Foundation for Research in Ophthalmology

相似试验